✨ Medicines Notices
8 SEPTEMBER 2011 NEW ZEALAND GAZETTE, No. 138 3943
Product: Your Pharmacy Nasal Congestion Relief PE (General Sale)
Active Ingredient: Phenylephrine hydrochloride 12.2mg
Dosage Form: Capsule
New Zealand Sponsor: Orion Laboratories (NZ) Limited
Manufacturer: Wrafton Laboratories Limited, Devon, United Kingdom
Product: Your Pharmacy Nasal Congestion Relief PE (Pharmacy only)
Active Ingredient: Phenylephrine hydrochloride 12.2mg
Dosage Form: Capsule
New Zealand Sponsor: Orion Laboratories (NZ) Limited
Manufacturer: Wrafton Laboratories Limited, Devon, United Kingdom
Dated this 31st day of August 2011.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go6137
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Streptase
Active Ingredient: Streptokinase 250000IU
Dosage Form: Powder for injection
New Zealand Sponsor: CSL Biotherapies (NZ) Limited
Manufacturer: CSL Behring GmbH, Marburg, Germany
Product: Streptase
Active Ingredient: Streptokinase 1500000IU
Dosage Form: Powder for injection
New Zealand Sponsor: CSL Biotherapies (NZ) Limited
Manufacturer: CSL Behring GmbH, Marburg, Germany
Dated this 1st day of September 2011.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go6138
Classification of Medicines
Pursuant to section 106(1) of the Medicines Act 1981, I, Dr Don Mackie, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health, acting under delegated authority, hereby declare that:
- The medicine pseudoephedrine at any concentration and its salts and esters at any concentration are classified as prescription medicines.
Dated this 1st day of September 2011.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health.
go6140
Misuse of Drugs Regulations 1977
Restriction on Supply of Ephedrine and Pseudoephedrine—Approval to Prescribe, Supply and Administer Ephedrine and Pseudoephedrine
Pursuant to Regulation 22 of the Misuse of Drugs Regulations 1977, I, Stewart Jessamine, Group Manager, Medsafe, Ministry of Health, acting under delegated authority from the Minister of Health, hereby make the following approval:
That from 8 September 2011 ephedrine and pseudoephedrine (controlled drugs described in Part 2 of Schedule 2 of the Misuse of Drugs Act 1975) may be prescribed or supplied or administered by the classes of persons described, and in the circumstances set out in the Schedule.
Next Page →
✨ LLM interpretation of page content
🏥 Consent to Distribution of Nasal Congestion Relief PE
🏥 Health & Social Welfare31 August 2011
Medicines, Distribution, Nasal Congestion Relief, Phenylephrine hydrochloride
- DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
🏥
Consent to the Distribution of New Medicines
(continued from previous page)
🏥 Health & Social Welfare1 September 2011
Medicines, Distribution, Streptase, Streptokinase
- DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
🏥 Classification of Pseudoephedrine as Prescription Medicine
🏥 Health & Social Welfare1 September 2011
Medicines, Classification, Pseudoephedrine, Prescription
- DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
🏥 Approval to Prescribe, Supply, and Administer Ephedrine and Pseudoephedrine
🏥 Health & Social WelfareMedicines, Ephedrine, Pseudoephedrine, Prescription, Supply
- Stewart Jessamine, Group Manager, Medsafe, Ministry of Health
NZ Gazette 2011, No 138